Author Search Results

1

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

by Chiu J, Michael NL, Pitsuttihum P, Nitayaphan S, Sukwit S, Eamsila C, Ratto-Kim S, Chantakulkij S, Kaewkungwal J, Trichavaroj R, Kamasuta C, Kim JH, Rerks-Ngarm S, de Souza MS, Paris RM
Published 2009-10-01

Article
2

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

by Francis D, Tartaglia J, Rerks-Ngam S, Dally L, Nitayaphan S, Ratto-Kim S, Jongrakthaitae S, Phuang-ngem Y, Chuenarom W, Schuetz A, Trichavaroj R, de Souza MS, Michael NL, Paris RM, Kim JH
Published 2009-10-01

Article
3

Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection

by Ananworanich, J., Anderson, J., Buranapraditkun, S., Chomchey, N., Chottanapund, S., Colby, D.J, David, C., de Souza, M., Douek, D.C, Haase, A., Helgeson, E., Kroon, E., Manasnayakorn, S., Phanuphak, N., Pinyakorn, S., Prueksakaew, P., Reilly, C., Robb, M.L, Sacdalan, C., Schacker, T.W, Schuetz, A., Tovanabutra, S., Trichavaroj, R., Vasan, S., Zulk, J.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article